1 – 250 of 256
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Recombinant factor IX Fc for the treatment of hemophilia B
(
- Contribution to journal › Scientific review
-
Mark
Prophylactic Treatment of Children with Hemophilia in Sweden
(
- Contribution to journal › Scientific review
-
Mark
International Prophylaxis Study Group (IPSG) haemophilia joint MRI scale version 2.0
(
- Contribution to journal › Letter
-
Mark
Origin of pathogenic variant and mosaicism in families with a sporadic case of haemophilia B
2024) In Haemophilia(
- Contribution to journal › Article
-
Mark
Clinical Implications of Discrepancy between One-stage Clotting and Chromogenic Factor IX Activity in Haemophilia B
(
- Contribution to journal › Article
- 2023
-
Mark
Factor VIII genotype and the risk of developing high-responding or low-responding inhibitors in severe hemophilia A : data from the PedNet Hemophilia Cohort of 1,202 children
(
- Contribution to journal › Article
-
Mark
Haemophilia A and B - evaluation of the Swedish prophylactic regimen by magnetic resonance imaging
(
- Contribution to journal › Article
-
Mark
F8/F9 variants in the population-based PedNet Registry cohort compared with locus-specific genetic databases of the European Association for Haemophilia and Allied Disorders and the Centers for Disease Control and Prevention Hemophilia A or Hemophilia B Mutation Project.
(
- Contribution to journal › Article
-
Mark
Primary prophylaxis in children with severe haemophilia A and B-Implementation over the last 20 years as illustrated in real-world data in the PedNet cohorts
(
- Contribution to journal › Article
-
Mark
BAY 81-8973 Efficacy and Safety in Previously Untreated and Minimally Treated Children with Severe Hemophilia A : The LEOPOLD Kids Trial
(
- Contribution to journal › Article
- 2022
-
Mark
Silent variant in F8:c.222G>T (p.Thr74Thr) causes a partial exon skipping in a patient with mild hemophilia A
(
- Contribution to journal › Article
-
Mark
Autologous cell therapy - A new concept to eradicate inhibitors in haemophilia
(
- Contribution to journal › Letter
- 2021
-
Mark
Inhibitor incidence in an unselected cohort of previously untreated patients with severe haemophilia B : a PedNet study
(
- Contribution to journal › Article
-
Mark
Droplet digital PCR and mile-post analysis for the detection of F8 int1h inversions
(
- Contribution to journal › Article
-
Mark
Identification of F8 rearrangements in carrier and non-carrier mothers of haemophilia A patients
(
- Contribution to journal › Letter
-
Mark
Principles of Care for Acquired Hemophilia
(
- Contribution to journal › Article
-
Mark
Practical considerations for nonfactor-replacement therapies in the treatment of haemophilia with inhibitors
(
- Contribution to journal › Scientific review
- 2020
-
Mark
Genetic screening of children with suspected inherited bleeding disorders
(
- Contribution to journal › Article
-
Mark
Detection of F8 int22h inversions using digital droplet PCR and mile-post assays
(
- Contribution to journal › Article
-
Mark
Novel F8 and F9 gene variants from the PedNet Hemophilia Registry classified according to ACMG/AMP guidelines
(
- Contribution to journal › Article
-
Mark
Long-term follow-up of neonatal intracranial haemorrhage in children with severe haemophilia
(
- Contribution to journal › Letter
-
Mark
Detection of mosaics in hemophilia A by deep Ion Torrent sequencing and droplet digital PCR
(
- Contribution to journal › Article
-
Mark
Registries and databases : A European perspective
(
- Contribution to journal › Article
-
Mark
Continued benefit demonstrated with BAY 81-8973 prophylaxis in previously treated children with severe haemophilia A : Interim analysis from the LEOPOLD Kids extension study
(
- Contribution to journal › Article
- 2019
-
Mark
Targeted re-sequencing of F8, F9 and VWF : Characterization of Ion Torrent data and clinical implications for mutation screening
(
- Contribution to journal › Article
-
Mark
Inhibitors in haemophilia A and B : Management of bleeds, inhibitor eradication, and strategies for difficult-to-treat patients
(
- Contribution to journal › Scientific review
-
Mark
Mode of delivery in hemophilia : Vaginal delivery and Cesarean section carry similar risks for intracranial hemorrhages and other major bleeds
(
- Contribution to journal › Article
-
Mark
Sports participation and physical activity in adult Dutch and Swedish patients with severe haemophilia : A comparison between intermediate- and high-dose prophylaxis
(
- Contribution to journal › Article
-
Mark
Recombinant factor VIII products and inhibitor development in previously untreated patients with severe haemophilia A : Combined analysis of three studies
(
- Contribution to journal › Article
-
Mark
Timing of inhibitor development in more than 1000 previously untreated patients with severe hemophilia A
(
- Contribution to journal › Letter
- 2018
-
Mark
Practical aspects of extended half-life products for the treatment of haemophilia
(
- Contribution to journal › Scientific review
-
Mark
Diagnosis and care of patients with mild haemophilia : practical recommendations for clinical management
(
- Contribution to journal › Scientific review
-
Mark
Prevention and Management of Bleeding Episodes in Children with Hemophilia
(
- Contribution to journal › Article
-
Mark
How I manage patients with inherited haemophilia A and B and factor inhibitors
(
- Contribution to journal › Scientific review
-
Mark
Haemophilia B : Where are we now and what does the future hold?
(
- Contribution to journal › Scientific review
- 2017
-
Mark
Beyond stopping the bleed: short-term episodic prophylaxis with recombinant activated factor FVII in haemophilia patients with inhibitors.
(
- Contribution to journal › Article
-
Mark
Discrepancies between the one-stage clotting assay and the chromogenic assay in haemophilia B
(
- Contribution to journal › Article
-
Mark
Primary prophylaxis in haemophilia care : Guideline update 2016
(
- Contribution to journal › Article
-
Mark
Plasma products do not solve the inhibitor problem
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Intracranial haemorrhage in children and adolescents with severe haemophilia A or B - the impact of prophylactic treatment
(
- Contribution to journal › Article
-
Mark
Outcome measures for adult and pediatric hemophilia patients with inhibitors
(
- Contribution to journal › Scientific review
-
Mark
Risk Factors for the Progression from Low to High Titres in 260 Children with Severe Haemophilia A and Newly Developed Inhibitors
(
- Contribution to journal › Article
-
Mark
The care of a child with a newly diagnosed immune thrombocytopenia
(
- Contribution to journal › Debate/Note/Editorial
- 2016
-
Mark
BAY 81-8973 safety and efficacy for prophylaxis and treatment of bleeds in previously treated children with severe haemophilia A: results of the LEOPOLD Kids Trial.
(
- Contribution to journal › Article
-
Mark
Practical considerations in choosing a factor VIII prophylaxis regimen: Role of clinical phenotype and trough levels.
(
- Contribution to journal › Scientific review
-
Mark
Evaluating outcome of prophylaxis in haemophilia: objective and self-reported instruments should be combined.
2016) In Haemophilia(
- Contribution to journal › Article
-
Mark
Origin of mutation in sporadic cases of severe haemophilia A in Sweden.
(
- Contribution to journal › Article
-
Mark
Inhibitor development in previously untreated patients with severe haemophilia A : a nationwide multicentre study in Finland
(
- Contribution to journal › Article
-
Mark
Increased inhibitor incidence in severe haemophilia A since 1990 attributable to more low titre inhibitors
(
- Contribution to journal › Article
-
Mark
Pain and pain management in haemophilia
(
- Contribution to journal › Scientific review
-
Mark
Aspects of prophylactic treatment of hemophilia
(
- Contribution to journal › Scientific review
-
Mark
Phenotype and genotype comparisons in carriers of haemophilia A
(
- Contribution to journal › Article
- 2015
-
Mark
Tailoring care to haemophilia patients' needs: which specialty and when?
(
- Contribution to journal › Article
-
Mark
The current status of prophylactic replacement therapy in children and adults with haemophilia.
(
- Contribution to journal › Scientific review
-
Mark
Various regimens for prophylactic treatment of patients with haemophilia
(
- Contribution to journal › Scientific review
-
Mark
Bleeding before prophylaxis in severe hemophilia: paradigm shift over two decades.
(
- Contribution to journal › Letter
-
Mark
Can a "center effect" explain the higher frequency of inhibitors for a second generation recombinant factor VIII product?
(
- Contribution to journal › Letter
-
Mark
How to achieve full prophylaxis in young boys with severe haemophilia A: different regimens and their effect on early bleeding and venous access
(
- Contribution to journal › Article
-
Mark
Rationale for individualizing haemophilia care.
(
- Contribution to journal › Scientific review
-
Mark
Switching treatments in haemophilia: is there a risk of inhibitor development?
(
- Contribution to journal › Scientific review
-
Mark
Mutation analysis of Swedish haemophilia B families - high frequency of unique mutations.
2015) In Haemophilia(
- Contribution to journal › Article
-
Mark
Hematologi
2015) p.237-246(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2014
-
Mark
Definitions in hemophilia: communication from the SSC of the ISTH
(
- Contribution to journal › Article
-
Mark
Prenatal diagnosis of haemophilia in Sweden now more commonly used for psychological preparation than termination of pregnancy.
(
- Contribution to journal › Article
-
Mark
Factor VIII therapy for hemophilia A: current and future issues
(
- Contribution to journal › Scientific review
-
Mark
Clotting factor level is not a good predictor of bleeding in carriers of haemophilia A and B.
(
- Contribution to journal › Article
-
Mark
Prospective observational cohort studies for studying rare diseases: the European PedNet Haemophilia Registry
(
- Contribution to journal › Article
-
Mark
Perinatal aspects of haemophilia
(
- Contribution to journal › Scientific review
-
Mark
Textbook of hemophilia : Care of the child with hemophilia
2014) p.145-150(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Similar bleeding phenotype in young children with haemophilia A or B : A cohort study
(
- Contribution to journal › Article
-
Mark
Joint disease, the hallmark of haemophilia: What issues and challenges remain despite the development of effective therapies?
(
- Contribution to journal › Scientific review
- 2013
-
Mark
Increased burden on caregivers of having a child with haemophilia complicated by inhibitors.
2013) In Pediatric Blood & Cancer(
- Contribution to journal › Article
-
Mark
Origin of Swedish hemophilia B mutations
(
- Contribution to journal › Article
-
Mark
40K glycoPEGylated, recombinant FVIIa: 3-month, double-blind, randomized trial of safety, pharmacokinetics, and preliminary efficacy in hemophilia patients with inhibitors.
(
- Contribution to journal › Article
-
Mark
Novel coagulation factor concentrates: Issues relating to their clinical implementation and pharmacokinetic assessment for optimal prophylaxis in haemophilia patients.
(
- Contribution to journal › Scientific review
-
Mark
Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study
(
- Contribution to journal › Article
-
Mark
Factor VIII Products and Inhibitor Development in Severe Hemophilia A
(
- Contribution to journal › Article
-
Mark
Intermediate- dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s
(
- Contribution to journal › Article
-
Mark
Correlation between phenotype and genotype in a large unselected cohort of children with severe hemophilia A
(
- Contribution to journal › Article
-
Mark
Hemophilia and prophylaxis.
(
- Contribution to journal › Scientific review
- 2012
-
Mark
Haemophilia Care in Europe: the ESCHQoL study
(
- Contribution to journal › Article
-
Mark
Beyond patient benefit: clinical development in hemophilia
(
- Contribution to journal › Scientific review
-
Mark
Origin of Swedish hemophilia A mutations
(
- Contribution to journal › Article
-
Mark
Investigation of disease-associated factors in haemophilia A patients without detectable mutations.
(
- Contribution to journal › Article
-
Mark
An MRI scale for assessment of haemophilic arthropathy from the International Prophylaxis Study Group.
(
- Contribution to journal › Article
-
Mark
Immune tolerance induction in patients with severe hemophilia with inhibitors: expert panel views and recommendations for clinical practice.
(
- Contribution to journal › Article
-
Mark
How to manage invasive procedures in children with haemophilia.
(
- Contribution to journal › Article
-
Mark
Konstitutionella anemier
2012) p.241-253(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Optimizing joint function : new knowledge and novel tools and treatments
(
- Contribution to journal › Article
- 2011
-
Mark
Modern treatment options for von Willebrand disease and haemophilia B - What are the benefits for the patients?
(
- Contribution to journal › Article
-
Mark
The need for speed in the management of haemophilia patients with inhibitors
(
- Contribution to journal › Article
-
Mark
Delivery of a severe haemophilia foetus - vaginal delivery
(
- Contribution to journal › Published meeting abstract
-
Mark
Report of the Fifth Meeting of the International Network for Pediatric Hemophilia: a focus on prophylaxis and immune tolerance induction.
2011) In International Journal of Hematology(
- Contribution to journal › Article
-
Mark
Anemier
2011) p.239-251(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Hematologi
2011) p.406-417(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Thirty-years' experience of prenatal diagnosis of haemophilia in Sweden
2011) XXIII Congress of the International Society on Thrombosis and Haemostasis In Journal of Thrombosis and Haemostasis 9. p.462-462(
- Contribution to journal › Published meeting abstract
-
Mark
Joint protection in haemophilia
(
- Contribution to journal › Article
- 2010
-
Mark
European Initiative to prevent joint damage in haemophilia children with inhibitors (ENJOIH) - a prospective study
(
- Contribution to journal › Published meeting abstract
-
Mark
Why is the frequency of inhibitors increasing among Swedish children with severe hemophilia A?
(
- Contribution to journal › Published meeting abstract
-
Mark
The role of prophylaxis in bleeding disorders
(
- Contribution to journal › Scientific review
-
Mark
Devising a best practice approach to prophylaxis in boys with severe haemophilia: evaluation of current treatment strategies
(
- Contribution to journal › Scientific review
-
Mark
Prophylaxis in hemophilia
(
- Contribution to journal › Published meeting abstract
-
Mark
Hemophilia A patients without detectable mutations - investigation of disease-associated factors
(
- Contribution to journal › Published meeting abstract
-
Mark
Quality of life in parents of children with haemophilia - results of the ESCHQoL study
(
- Contribution to journal › Published meeting abstract
-
Mark
European initiative to prevent joint damage in haemophilia children with inhibitors (ENJOIH) - a prospective study
(
- Contribution to journal › Published meeting abstract
-
Mark
Mild haemophilia in Sweden
(
- Contribution to journal › Published meeting abstract
-
Mark
The Fourth Annual Meeting of the International Network for Pediatric Hemophilia: Current Challenges and Recommendations in the Clinical Care of Children with Hemophilia.
(
- Contribution to journal › Article
-
Mark
Anti-prothrombin antibodies are associated with thrombosis in children.
(
- Contribution to journal › Article
-
Mark
The optimal mode of delivery for the haemophilia carrier expecting an affected infant is vaginal delivery.
(
- Contribution to journal › Article
-
Mark
Care of the Child with Hemophilia
2010) p.127-132(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
42. Blödningssjukdomar och tromboser
2010) p.331-337(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2009
-
Mark
Prophylactic therapy in haemophilia.
(
- Contribution to journal › Scientific review
-
Mark
Paediatric haemophilia with inhibitors: existing management options, treatment gaps and unmet needs
(
- Contribution to journal › Scientific review
-
Mark
Successful thrombolysis of neonatal bilateral renal vein thrombosis originating in the IVC.
(
- Contribution to journal › Article
-
Mark
Lower incidence of procoagulant abnormalities during follow-up after creation of the Fontan circulation in children.
(
- Contribution to journal › Article
- 2008
-
Mark
Venous access - why such diverse experiences of central venous lines?
2008) XXVIIIth International Congress of the World Federation of Hemophilia, 2008 In Haemophilia 14(s2). p.96-96(
- Contribution to journal › Published meeting abstract
-
Mark
Management of delivery and neonatal period
2008) XXVIIIth International Congress of the World Federation of Hemophilia, 2008 In Haemophilia 14(s2). p.5-5(
- Contribution to journal › Published meeting abstract
-
Mark
Musculoskeletal measurement tools from the International Prophylaxis Study Group (IPSG)
(
- Contribution to journal › Article
-
Mark
Quality of life in haemophilia carriers - preliminary results of the ESCHQoL study
2008) XXVIIIth International Congress of the World Federation of Hemophilia, 2008 In Haemophilia 14(s2). p.150-150(
- Contribution to journal › Published meeting abstract
-
Mark
Management of carriers and babies with haemophilia
(
- Contribution to journal › Article
-
Mark
Secondary prophylaxis with recombinant activated factor VII improves health-related quality of life of haemophilia patients with inhibitors
(
- Contribution to journal › Article
-
Mark
Female haemophilia A caused by skewed X inactivation
(
- Contribution to journal › Letter
-
Mark
Prophylaxis for severe haemophilia: clinical challenges in the absence as well as in the presence of inhibitors
(
- Contribution to journal › Article
-
Mark
Haemophilia in the first years of life.
(
- Contribution to journal › Article
-
Mark
Intracranial haemorrhage in haemophilia A and B.
(
- Contribution to journal › Scientific review
-
Mark
Why does the mutation G17736A/Val107Val (silent) in the F9 gene cause mild haemophilia B in five Swedish families?
(
- Contribution to journal › Article
-
Mark
Venous Access in Children with Inhibitors
2008) p.36-41(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2007
-
Mark
The risk associated with indwelling catheters in children with haemophilia.
(
- Contribution to journal › Scientific review
-
Mark
Prevention of bleeding in haemophilia: trends, overcoming barriers and future treatment options
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
The thalassaemia syndromes
(
- Contribution to journal › Scientific review
-
Mark
Gadolinium Contrast Agent is of Limited Value for Magnetic Resonance Imaging Assessment of Synovial Hypertrophy in Hemophiliacs.
(
- Contribution to journal › Article
- 2006
-
Mark
Studies of chronic ITP in children and adolescents.
(
- Contribution to journal › Article
-
Mark
Development of a disease-specific quality of life questionnaire for children & adolescents with idiopathic thrombocytopenic purpura (ITP-QoL)
(
- Contribution to journal › Article
-
Mark
Are randomized clinical trials the only truth? Not always
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Functional Analysis of the Factor IX Epidermal Growth Factor-Like Domain Mutation Ile66Thr Associated with Mild Hemophilia B.
(
- Contribution to journal › Article
-
Mark
Talassemi i Sverige – Behandlingsmål och uppföljning varierar kraftigt.
(
- Contribution to journal › Article
-
Mark
Current co-ordinated activities of the PEDNET (European Paediatric Network for Haemophilia Management)
(
- Contribution to journal › Article
- 2005
-
Mark
Changing pattern of care of boys with haemophilia in western European centres
(
- Contribution to journal › Article
-
Mark
MRI scores of ankle joints in children with haemophilia--comparison with clinical data.
(
- Contribution to journal › Article
-
Mark
Compatible scales for progressive and additive MRI assessments of haemophilic arthropathy.
(
- Contribution to journal › Article
-
Mark
Akut hematologi i nyföddhetsperioden
2005)(
- Book/Report › Book
-
Mark
Risk factors for venous thrombosis in Swedish children and adolescents.
(
- Contribution to journal › Article
-
Mark
Blödningssjukdomar och tromboser
2005)(
- Book/Report › Book
- 2004
-
Mark
Central venous catheters in children with haemophilia.
(
- Contribution to journal › Scientific review
-
Mark
Optimizing factor prophylaxis for the haemophilia population: where do we stand?
(
- Contribution to journal › Article
-
Mark
Untitled - Introduction
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
A new magnetic resonance imaging scoring method for assessment of haemophilic arthropathy.
(
- Contribution to journal › Article
-
Mark
Care of the child with haemophilia.
2004)(
- Book/Report › Book
-
Mark
Introduction
(
- Contribution to journal › Debate/Note/Editorial
- 2003
-
Mark
Consensus perspectives on prophylactic therapy for haemophilia: summary statement.
(
- Contribution to journal › Letter
-
Mark
Third and Fourth Workshops of the European paediatric network for haemophilia management.
(
- Contribution to journal › Article
-
Mark
Central venous lines in haemophilia.
(
- Contribution to journal › Article
-
Mark
Functional analysis of the EGF-like domain mutations Pro55Ser and Pro55Leu, which cause mild hemophilia B.
(
- Contribution to journal › Article
-
Mark
Genetic counselling of haemophilia carriers
(
- Contribution to journal › Article
- 2002
-
Mark
Paediatric care of the child with haemophilia.
(
- Contribution to journal › Article
-
Mark
Breastfeeding does not influence the development of inhibitors in haemophilia.
(
- Contribution to journal › Article
-
Mark
Aspects of haemophilia prophylaxis in Sweden.
(
- Contribution to journal › Article
-
Mark
Inhibitors in the Swedish population with severe haemophilia A and B : A 20-year survey
(
- Contribution to journal › Article
-
Mark
Venous access in children with inhibitors.
2002) p.36-36(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2001
-
Mark
Optimal treatments for patients with bleeding disorders.
(
- Contribution to journal › Letter
-
Mark
Haemophilia B mutations in Sweden: a population-based study of mutational heterogeneity
(
- Contribution to journal › Article
-
Mark
Broad spectrum of time of detection, primary symptoms and disease progression in infants with HIV-1 infection
(
- Contribution to journal › Article
-
Mark
Somatic mosaicism in hemophilia A: A fairly common event
(
- Contribution to journal › Article
-
Mark
Symposium in memory of Professor Inga Marie Nilsson
(
- Contribution to journal › Published meeting abstract
- 2000
-
Mark
Factor VIII inhibitors in two families with mild haemophilia A: structural analysis of the mutations
(
- Contribution to journal › Article
-
Mark
The Malmo model for immune tolerance induction: impact of previous treatment on outcome
(
- Contribution to journal › Article
-
Mark
Treatment of children with haemophilia in Europe: A survey of 20 centres in 16 countries
(
- Contribution to journal › Article
- 1999
-
Mark
Haemophilia B carrier detection by factor IX:C analysis; no impact of the type of mutation or severity of disorder
(
- Contribution to journal › Article
-
Mark
Centraliserad vård grundläggande i vårdprogram för blödarsjuka
(
- Contribution to journal › Article
-
Mark
Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized
(
- Contribution to journal › Article
-
Mark
How do carriers of hemophilia and their spouses experience prenatal diagnosis by chorionic villus sampling?
(
- Contribution to journal › Article
-
Mark
Origin of mutation in sporadic cases of haemophilia A
(
- Contribution to journal › Article
-
Mark
Prenatal diagnosis of haemophilia
(
- Contribution to journal › Scientific review
-
Mark
Long-term psychological effects of carrier testing and prenatal diagnosis of haemophilia: Comparison with a control group
(
- Contribution to journal › Article
-
Mark
Long-term pattern of HIV-1 RNA load in perinatally infected children
(
- Contribution to journal › Article
-
Mark
Second Workshop of the European Paediatric Network for Haemophilia Management, Vitznau, Switzerland, 17-19 September 1998
(
- Contribution to journal › Article
-
Mark
Prophylactic infusion regimens in the management of hemophilia
(
- Contribution to journal › Article
-
Mark
Reproductive choices of haemophilia carriers
(
- Contribution to journal › Article
- 1998
-
Mark
Port-A-Cath usage in children with haemophilia : Experience of 53 cases
(
- Contribution to journal › Article
-
Mark
A meeting held in London, 12-13 January 1998, to discuss bleeding disorders in women
(
- Contribution to journal › Article
-
Mark
Anaphylactoid reactions and nephrotic syndrome - A considerable risk during factor IX treatment in patients with haemophilia B and inhibitors : A report on the outcome in two brothers
(
- Contribution to journal › Article
-
Mark
Prophylactic treatment in Sweden - Overtreatment or optimal model?
(
- Contribution to journal › Article
-
Mark
Can haemophilic arthropathy be prevented?
(
- Contribution to journal › Special issue (editor)
- 1997
-
Mark
High prevalence of thyroid autoantibodies at diagnosis of insulin-dependent diabetes mellitus in Swedish children
(
- Contribution to journal › Article
-
Mark
Identifying carriers at high risk for negative reactions when performing prenatal diagnosis of haemophilia
(
- Contribution to journal › Article
-
Mark
Factor IX inhibitors and anaphylaxis in hemophilia B
(
- Contribution to journal › Article
-
Mark
Improved cost-effectiveness by pharmacokinetic dosing of factor VIII in prophylactic treatment of haemophilia A
(
- Contribution to journal › Article
- 1996
-
Mark
Rätt och fel om talassemidiagnostik : Kommentar
(
- Contribution to specialist publication or newspaper › Specialist publication article
-
Mark
Talassemi på väg in i landet : Ny patientgrupp på svenska barnkliniker
(
- Contribution to specialist publication or newspaper › Specialist publication article
-
Mark
Detection of virus in vertically exposed HIV-antibody-negative children
(
- Contribution to journal › Article
-
Mark
Emergence of novel transient clonal chromosomal bone marrow changes in remission of acute lymphoblastic leukemia
(
- Contribution to journal › Article
-
Mark
Four novel mutations in deficiency of coagulation factor XIII: Consequences to expression and structure of the A-subunit
(
- Contribution to journal › Article
-
Mark
Prenatal diagnosis of haemophilia
(
- Contribution to journal › Article
-
Mark
Molecular basis of factor xiii deficiency H.Mikkola
(
- Contribution to journal › Article
- 1995
-
Mark
Inversions of the factor VIII gene in Swedish patients with severe haemophilia A
(
- Contribution to journal › Article
-
Mark
Gene mutations and inhibitor formation in patients with hemophilia B
(
- Contribution to journal › Article
-
Mark
The impact of prenatal diagnosis on the incidence of haemophilia in Sweden
(
- Contribution to journal › Article
-
Mark
Factor VIII gene inversions in severe hemophilia A : Results of an international consortium study
(
- Contribution to journal › Article
- 1994
-
Mark
Kartläggning av familjer i Sverige med hemofili B : Nästan alla undersökta har unika mutationer
(
- Contribution to specialist publication or newspaper › Specialist publication article
-
Mark
Prophylactic treatment of severe hemophilia A and B can prevent joint disability
(
- Contribution to journal › Article
-
Mark
Normal vaginal delivery is to be recommended for haemophilia carrier gravidae
(
- Contribution to journal › Article
-
Mark
Haemoglobin Koln as de novo mutations in Sweden : Diagnosis by PCR and specific enzymatic cleavage
(
- Contribution to journal › Article
-
Mark
Genetic diagnosis of hemophilia a
(
- Contribution to journal › Article
-
Mark
High titer inhibitors in severe haemophilia A. A meta-analysis based on eight long-term follow-up studies concerning inhibitors associated with crude or intermediate purity factor VIII products [4]
(
- Contribution to journal › Letter
-
Mark
The feasibility of long-term venous access in children with hemophilia
(
- Contribution to journal › Article
-
Mark
Intron 22 Inversions and haemophilia
(
- Contribution to journal › Letter
- 1993
-
Mark
Haemophilia : strategies for carrier detection and prenatal diagnosis
(
- Contribution to journal › Article
-
Mark
Piebaldism in a mentally retarded girl with rare deletion of the long arm of chromosome 4
(
- Contribution to journal › Article
-
Mark
HIV infection in haemophilia - A European cohort
(
- Contribution to journal › Article
-
Mark
Report of a joint WHO/WFH meeting on the control of haemophilia: Carrier detection and prenatal diagnosis
(
- Contribution to journal › Article
-
Mark
Cost-effectiveness - Can it be measured?
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
- 1992
-
Mark
Direct estimate of the haemophilia B (factor IX deficiency) mutation rate and of the ratio of the sex-specific mutation rates in Sweden
(
- Contribution to journal › Article
-
Mark
Antenatal diagnosis of haemophilia B by amplification and electrophoresis of an exon fragment with a short deletion
(
- Contribution to journal › Article
-
Mark
Factor VIII and factor IX inhibitors in haemophiliacs
(
- Contribution to journal › Letter
-
Mark
Gaucher's disease in an infant diagnosed by fine needle aspiration of the liver and spleen : A case report
(
- Contribution to journal › Article
-
Mark
Haplotype analysis of identical factor IX mutants using PCR
(
- Contribution to journal › Article
-
Mark
Further characterization of the new marker at DXS115 with regard to carrier detection in hemophilia A
(
- Contribution to journal › Letter
-
Mark
Implantable central venous catheter facilitates prophylactic treatment in children with haemophilia
(
- Contribution to journal › Article
-
Mark
Origin of mutation in sporadic cases of haemophilia-B
(
- Contribution to journal › Article
-
Mark
Cholelithiasis during the first year of life : Case reports and literature review
(
- Contribution to journal › Article
- 1991
-
Mark
Moderate haemophilia B in a female carrier caused by preferential inactivation of the paternal X chromosome
(
- Contribution to journal › Article
-
Mark
More than half the sporadic cases of Hemophilia A in Sweden are due to a recent mutation
(
- Contribution to journal › Article
-
Mark
Population genetics of the Malmö polymorphism of coagulation factor IX
(
- Contribution to journal › Article
-
Mark
Haemophilia B mutations in a complete Swedish population sample : a test of new strategy for the genetic counselling of diseases with high mutational heterogeneity
(
- Contribution to journal › Article
-
Mark
A new strategy for carrier and prenatal diagnosis and molecular studies in haemophilia B
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
- 1990
-
Mark
Hepatitis C virus transmission by monoclonal antibody purified factor VIII concentrate
(
- Contribution to journal › Letter
-
Mark
The incidence and distribution of CpG----TpG transitions in the coagulation factor IX gene. A fresh look at CpG mutational hotspots
(
- Contribution to journal › Article
-
Mark
Two factor IX mutations in the family of an isolated haemophilia B patient : direct carrier diagnosis by amplification mismatch detection (AMD)
(
- Contribution to journal › Article
-
Mark
Diagnostic symptoms of severe and moderate haemophilia A and B. A survey of 140 cases
(
- Contribution to journal › Article
- 1989
-
Mark
How do carriers of hemophilia experience prenatal diagnosis (PND)? : Carriers' Immediate and later reactions to amniocentesis and fetal blood sampling
(
- Contribution to journal › Article
- 1988
-
Mark
The Malmo polymorphism of coagulation factor IX, an immunologic polymorphism due to dimorphism of residue 148 that is in linkage disequilibrium with two other F.IX polymorphisms
(
- Contribution to journal › Article
-
Mark
Neutropenia and congenital cytomegalovirus infection
(
- Contribution to journal › Letter
-
Mark
Hemofilivården i Sverige. Centraliserat ansvar ger hög vårdkvalitet.
(
- Contribution to specialist publication or newspaper › Specialist publication article
- 1987
-
Mark
Prenataldiagnostik av hemofili A och B genom chorionvillus-biopsi och DNA-analys.
(
- Contribution to journal › Article
-
Mark
How do carriers of hemophilia experience prenatal diagnosis by fetal blood sampling?
(
- Contribution to journal › Article
-
Mark
Determination of factor IX allotypes for carrier identification in haemophilia B
(
- Contribution to journal › Article
- 1986
-
Mark
Two allotypes of factor IX present in haemophilia B
(
- Contribution to journal › Article
-
Mark
Platelet-associated IgG in childhood idiopathic thrombocytopenic purpura : measurements on intact and solubilized platelets and after gammaglobulin treatment
(
- Contribution to journal › Article
-
Mark
Carrier detection in hemophilia A : a cooperative international study. II. The efficacy of a universal discriminant
(
- Contribution to journal › Article
-
Mark
Carrier detection in hemophilia A : a cooperative international study. I. The carrier phenotype
(
- Contribution to journal › Article
- 1985
-
Mark
High-dose intravenous gammaglobulin : a cautionary note
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Polymorphism of normal factor IX detected by mouse monoclonal antibodies
1985) In Proceedings of the National Academy of Sciences of the United States of America 82(11). p.3839-3843(
- Contribution to journal › Article
- 1984
-
Mark
Ganglioneuroma with an uncommon location in a six-year-old girl
(
- Contribution to journal › Article
- 1983
-
Mark
Detection of factor IX inhibitors by immunoradiometric assay
(
- Contribution to journal › Article
-
Mark
Suppression of Secondary Antibody Response by Intravenous Immunoglobulin in a Patient with Haemophilia B and Antibodies
(
- Contribution to journal › Article
-
Mark
The effects of plasmin and protein Ca on factor VIII:C and VIII:CAg
(
- Contribution to journal › Article
- 1982
-
Mark
Haemophilia A and B--two years experience of genetic counselling and prenatal diagnosis
(
- Contribution to journal › Article
-
Mark
Hemophilia B Leyden and a similar variant of hemophilia A.
(
- Contribution to journal › Letter
-
Mark
Immunoradiometric assay of inhibitors of antihaemophilic factor A
(
- Contribution to journal › Article
-
Mark
Genetic variants of haemophilia B detected by immunoradiometric assay : implications for prenatal diagnosis
(
- Contribution to journal › Article